Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
EOM Pharmaceuticals logo — company profile

EOM Pharmaceuticals

Founded 2020 United States United States 3 employees Health Care

General Information

Company Name EOM Pharmaceuticals
Founded Year 2020
Location United States United States +1
Employees 3
Industries Health Care
Social

Get notified when EOM Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EOM Pharmaceuticals

EOM Pharmaceuticals is a 2020-founded Health Care startup headquartered in the United States. The company is focused on developing and commercializing first-in-class treatments for a range of diseases, including COVID-19 and other infectious diseases, autoimmune diseases such as rheumatoid arthritis, cachexia associated with AIDS or cancer, and topical non-invasive treatments for sight-robbing retinal diseases. EOM Pharmaceuticals aims to address debilitating and potentially fatal conditions through relentless scientific innovation. Currently, the company has not disclosed its last investment or the involved investors, but its ambitious pursuit of breakthrough treatments positions it as an intriguing potential investment opportunity in the rapidly evolving healthcare sector. EOM Pharmaceuticals' focus on addressing critical unmet medical needs and the global healthcare challenges presents an exciting investment prospect for venture capitalists looking to support cutting-edge solutions with significant potential for impact and profitability.

Taxonomy: biopharmaceuticals, drug development, infectious diseases, autoimmune diseases, rheumatoid arthritis, cachexia, AIDS, cancer, retinal diseases, medical treatments

No funding data available for EOM Pharmaceuticals yet.

Get notified when EOM Pharmaceuticals raises funding

EOM Pharmaceuticals Alternatives & Competitors

EOM Pharmaceuticals vs
Gene Vector
Gene Vector

Pioneering the future of AAV gene therapy for ophthalmic, neuromuscular, genetic, and metabolic dise...

Series A
Biotechnology
EOM Pharmaceuticals vs
Ixchel Pharma
Ixchel Pharma

Pioneering the future of treatments for rare mitochondrial diseases with repurposed drug solutions.

2-10 employees
Pharmaceutical
EOM Pharmaceuticals vs
Lorantis
Lorantis

Creating innovative solutions for targeted treatment of immunological and inflammatory diseases from...

Series C
Health Care, Medical Devices

FAQ About EOM Pharmaceuticals

Powering relentless science by developing and commercializing first-in-class treatments to address debilitating and potentially fatal diseases, including COVID-19 and other infectious diseases; autoimmune diseases including rheumatoid arthritis; cachexia associated with AIDS or cancer; and topical n...
EOM Pharmaceuticals was founded in 2020.
EOM Pharmaceuticals is headquartered in United States.
EOM Pharmaceuticals operates in the following industries: Health Care.
EOM Pharmaceuticals has approximately 3 employees.
Top alternatives and competitors to EOM Pharmaceuticals include Gene Vector, Ixchel Pharma, Lorantis, Oxular, AltPep. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EOM Pharmaceuticals and Gene Vector are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EOM Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy